A 24-week, Phase 2, Double-blind, Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of 2 Doses of MRC375 in Patients With Moderate to Severe Rheumatoid Arthritis
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Tetracycline (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 01 Nov 2012 Official title amended as reported by ClinicalTrials.gov.
- 01 Nov 2012 Planned End Date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 05 Dec 2011 Actual initiation date (Nov 2011) added as reported by ClinicalTrials.gov.